Cargando…
Enhancing central noradrenergic function in depression: is there still a place for a new antidepressant?
Noradrenaline has long played a key role in the way the etiology of depression is conceptualized and in the mechanism of action of many current antidepressants. Tricyclic antidepressants (TCAs), monoamine oxidase inhibitors (MAOIs), serotonin-noradrenaline reuptake inhibitors (SNRIs), selective nora...
Autor principal: | Pinder, Roger M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2426812/ https://www.ncbi.nlm.nih.gov/pubmed/18568121 |
Ejemplares similares
-
Are Noradrenergic Transmission Reducing Drugs Antidepressants?
por: Fitzgerald, Paul J.
Publicado: (2021) -
Is There Still a Place to Study Race in the Nephrology Space?
por: Rifkin, Brian
Publicado: (2023) -
Percutaneous balloon mitral valvuloplasty: is there still a place for it in the Netherlands?
por: den Heijer, P.
Publicado: (2019) -
New antidepressants or more of the same?
por: Pinder, Roger M
Publicado: (2007) -
Noradrenergic therapies for apathy in Alzheimer’s disease?
por: Husain, Masud
Publicado: (2023)